Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • a blog post about some of the most common claim drafting issues “for biotech, chemical and pharma patent applications”;
  • an article about how “VLSI Technology LLC plans to appeal an administrative ruling that wiped out 12 of its microchip patent claims”; and
  • another article about “Jazz Pharmaceuticals Inc. . . . [urging] the Federal Circuit to undo a federal injunction forcing it to delist a narcolepsy drug-related patent.”
Read More